More creations to inspire you
Transcript
Antibiotics value chain
- Meriem, Sourya & Shradha
VALUE CHAIN
V/S
SUPPLY CHAIN
Porter's Value Chain
Antibiotic Value chain - Process
THE DISCOVERY VOID
CURRENT SCENARIO OF GLOBAL AMR
tHE challenges
The Solution
- Antibiotics production by EU €2970 million: 2018
- Italy, EU’s biggest producer of antibiotics, produced antibiotics accounting for €1020 million worth: 2018. (This could be because Italy over consumes antibiotics and also acts as an international exporter of antibiotics)
- Germany imported €710 million worth of antibiotics from non-EU Member States: 2018
- EU Member States imported antibiotics worth €5030 million: 2018
A 10-year bond is purchased by private investors and is government-backed, thereby reducing the
risk for investors.
Funds from the ACB (antibiotic
corporate bond) are injected into research companies that have fulfilled the
criteria for early development of an appropriate antibiotic against a profile of an identified public
health need.
References
- https://www.amractionfund.com/resources/its-time-to-fix-the-antibiotic-market
- ttps://ec.europa.eu/eurostat/web/products-eurostat-news/-/EDN-20191118-2
- https://www.wallstreetmojo.com/supply-chain-vs-value-chain/
- https://www.investopedia.com/ask/answers/043015/what-difference-between-value-chain-and-supply-chain.asp
- https://wellcome.org/news/why-is-it-so-hard-develop-new-antibiotics